 WILLIAMSVILLE, N.Y., April 01, 2021 GLOBE NEWSWIRE -- 22nd Century Group, Inc. NYSE American: XXII, a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hempcannabis research, announced today that it continues to be confident on the renewal of the FDAs proposed reduced nicotine mandate that would make all cigarettes minimally or non-addictive. By way of support, four former U.S. Food and Drug Administration FDA commissioners, Robert M. Califf, M.D. MACC; Scott Gottlieb, M.D.; Peggy Hamburg, M.D.; and, Jane Henney, M.D., spoke on a recent panel and were vocal in their endorsement of the mandate to limit the amount of nicotine in cigarettes to levels already achieved by 22nd Centurys reduced nicotine content cigarettes, VLN . 